SCHEMBL351920

SCHEMBL351920

c1cc(CCCc2ccncc2)ccn1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.65
LOXL2 Q9Y4K0 2/20 0.62
HRH3 Q9Y5N1 3/20 0.59
HRH4 Q9H3N8 2/20 0.59
NAAA Q02083 1/20 0.52
CYP1A2 P05177 5/20 0.50
CYP3A4 P08684 5/20 0.50
CYP2D6 P10635 4/20 0.50
CYP2C9 P11712 4/20 0.50
CYP2C19 P33261 4/20 0.50
ALDH1A1 P00352 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HIF1A Q16665 1/20 0.46
NPC1 O15118 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31673871 0.97 HRH1 (0.62) HRH1LOXL2HRH3HRH4NAAA
SCHEMBL28055322 0.97 HRH1 (0.62) HRH1LOXL2HRH3HRH4NAAA
SCHEMBL726645 0.94 HRH1 (0.73) HRH1LOXL2HRH3HRH4NAAA
SCHEMBL725306 0.91 HRH1 (0.77) HRH1LOXL2HRH3HRH4NAAA
SCHEMBL4413800 0.91 HRH1 (0.77) HRH1LOXL2HRH3HRH4NAAA
SCHEMBL2841394 0.91 HRH1 (0.77) HRH1LOXL2HRH3HRH4NAAA
SCHEMBL123539 0.89 CYP1A2 (0.61) HRH1LOXL2HRH3HRH4CYP1A2
Pyridine SCHEMBL19285795 0.89 HRH1 (0.56) HRH1LOXL2HRH3HRH4NAAA
Hydrochloric Acid SCHEMBL6419195 0.87 CYP1A2 (0.59) HRH1LOXL2HRH3HRH4CYP1A2
Iodide SCHEMBL8083284 0.87 CYP1A2 (0.59) HRH1LOXL2HRH3HRH4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12576387-B2 Porous metal-organic framework, method for producing the same, adsorbent, and method for separating carbon dioxide KABUSHIKI KAISHA TOSHIBA (JP) 2026-03-17 US claimed
EP-4649543-A1 TRANSFORMABLE BINDER COMPOSITION PROVIDING A PRINTABLE ELECTROLYTE COMPOSITION RISE Research Institutes of Sweden AB (SE) 2025-11-19 EP claimed
US-20250319443-A1 METHOD FOR MANUFACTURING A THIN-FILM COMPOSITE MEMBRANE FOR WATER TREATMENT, HAVING EXTREME ACID AND ALKALINE STABILITY KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2025-10-16 US claimed
CN-119875139-A Cu-based metal organic framework material NJU-Bai5, preparation method and application thereof 南京工业大学 2025-04-25 CN claimed
CN-119684070-A HFIP power assisting C (sp3) Direct methylation method of-H bond and application thereof 西南大学 2025-03-25 CN claimed
US-20240373736-A1 Materials and Methods to Improve the Stability of Metal Halide Perovskites THE UNIVERSITY OF TOLEDO (US) 2024-11-07 US claimed
WO-2024151203-A1 TRANSFORMABLE BINDER COMPOSITION PROVIDING A PRINTABLE ELECTROLYTE COMPOSITION Rise Research Institutes of Sweden AB (SE) 2024-07-18 WO claimed
CN-117816250-B Rhenium-based supported catalyst, preparation thereof and application thereof in synthesis of rose ether intermediate 山东新和成药业有限公司 2024-06-04 CN claimed
CN-115536854-B Cobalt-containing one-dimensional complex crystal material and preparation method and application thereof 天津理工大学 2024-05-28 CN claimed
CN-117816250-A Rhenium-based supported catalyst, preparation thereof and application thereof in synthesis of rose ether intermediate 山东新和成药业有限公司 2024-04-05 CN claimed
US-5331075-A Blend of polysiloxanes, one containing vinyl group and the other a silicon hydride group GENERAL ELECTRIC COMPANY (US) 1994-07-19 US claimed
US-5306336-A Consisting of cupric and cuprous ions, formaldehyde, formate ions, hydroxyl ions, alkali metal ions, monovalent counterion for copper, cuprous and cupric ion chelants MONSANTO COMPANY (US) 1994-04-26 US claimed
EP-0545591-A1 Heat curable organopolysiloxane compositions and preformed latent platinum catalysts GENERAL ELECTRIC COMPANY (US) 1993-06-09 EP claimed
US-5187101-A Of an iodide ion, sulfur dioxide, a basic mixture of an amino alcohol and a dipyridyl alkane, and a solvent; odorless, high speed MITSUBISHI KASEI CORPORATION (JP) 1993-02-16 US claimed
EP-0484622-A2 Electrolytic solution for Karl Fischer's coulometric titration and method for measuring water content using same Mitsubishi Chemical Corporation (JP) 1992-05-13 EP claimed
US-5021471-A Polyepoxides and epoxy resins modified by a pyridine compound and acid; solvent- and water-systems; coatings, molding materials and castings; chemical resistance; flexibility THE DOW CHEMICAL COMPANY (US) 1991-06-04 US claimed
US-5008168-A Trimethyl trihdroxyphenyl substituted benzene, triphenyl phosp hite CANON KABUSHIKI KAISHA (JP) 1991-04-16 US claimed
EP-0338504-A2 Photosensitive member for electrophotography CANON KABUSHIKI KAISHA (JP) 1989-10-25 EP claimed
US-4720464-A Electrolytes for Karl Fischer coulometric titration MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) 1988-01-19 US claimed
EP-0252637-A2 Composition for the adhesive activation of polymeric material, process for treating polymeric material with an adhesive activating composition and the polymeric material thus activated CELANESE CORPORATION (US) 1988-01-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12576387-B2 Porous metal-organic framework, method for producing the same, adsorbent, and method for separating carbon dioxide OXGR1, TET1, MT-CO2 HRH1 1864/4885LOXL2 260/4885HRH3 2046/4885
US-20240373736-A1 Materials and Methods to Improve the Stability of Metal Halide Perovskites SOD1, BMI1, VCL HRH1 4523/4885LOXL2 1181/4885HRH3 3546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.